PREVALENCE OF DEPRESSIVE SYMPTOMS AMONG CHILDREN AND ADOLESCENTS WITH RHEUMATIC DISEASES
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.4785Keywords:
Juvenile Idiopathic Arthritis, Childhood-Onset Systemic Lupus Erythematosus, Juvenile Fibromyalgia, Depression, Rheumatology, PaediatricsAbstract
Background. Although rheumatic disorders are commonly associated with adulthood, a considerable number of cases occur in children and adolescents. Paediatric rheumatic diseases such as juvenile idiopathic arthritis (JIA), childhood-onset systemic lupus erythematosus (cSLE) and juvenile fibromyalgia (JFM) are chronic conditions that significantly affect everyday activities and quality of life.
Aim. This review aims to condense existing evidence regarding the prevalence of depressive symptoms among affected children and adolescents while emphasizing methodological challenges that shape reported outcomes.
Material and methods. The literature search was conducted in PubMed (2013–2025) using terms related to depression, JIA, cSLE, JFM, rheumatology and paediatrics. Studies including children and adolescents were analysed, while adult-only papers were excluded.
Results. Beyond physical symptoms JIA, cSLE, and JFM increase vulnerability to depressive symptoms. It is an under-recognised burden among paediatric patients. Despite this, the available research remains scarce, outdated, and methodologically inconsistent.
Conclusion. Across the studies, depressive symptoms were consistently more common in paediatric rheumatologic patients than in healthy peers. However, prevalence varied widely depending on the assessment method. Self-report questionnaires detected far higher rates than clinical diagnoses. Early psychiatric screening and appropriate psychological support are crucial, as the visibility of rheumatic symptoms (e.g., joint deformities, rashes, mobility impairments) and the resulting difficulties with social integration may further exacerbate emotional distress. Improving understanding of these associations will contribute to better clinical care and enhanced quality of life for this vulnerable patient population.
References
van der Heijde, D., Daikh, D. I., Betteridge, N., Burmester, G. R., Hassett, A. L., Matteson, E. L., van Vollenhoven, R., & Lakhanpal, S. (2018). Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Annals of the Rheumatic Diseases, 77(6), 829–832. https://doi.org/10.1002/art.40448
Żuber, Z., Podwójcic, K., Szeląg, M., Krajewska-Włodarczyk, M., Batko, K., Orleański, M., Sowiński, J., Świderek, M., Śmiglewska, A., Maluchnik, M., Brzosko, M., Kwiatkowska, B., Stajszczyk, M., & Batko, B. (2025). Epidemiology and comorbidity of juvenile idiopathic arthritis in Poland: A nationwide study. Pediatric Rheumatology Online Journal, 23(1), 33. https://doi.org/10.1186/s12969-025-01065-8
Valenzuela-Almada, M. O., Hocaoglu, M., Dabit, J. Y., Osei-Onomah, S. A., Basiaga, M. L., Orandi, A. B., Giblon, R. E., Barbour, K. E., Crowson, C. S., & Duarte-García, A. (2022). Epidemiology of childhood-onset systemic lupus erythematosus: A population-based study. Arthritis Care & Research, 74(5), 728–732. https://doi.org/10.1002/acr.24827
Coles, M. L., Weissmann, R., & Uziel, Y. (2021). Juvenile primary fibromyalgia syndrome: Epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis. Pediatric Rheumatology Online Journal, 19(1), 22. https://doi.org/10.1186/s12969-021-00493-6
Dregan, A., Matcham, F., Harber-Aschan, L., Rayner, L., Brailean, A., Davis, K., Hatch, S., Pariante, C., Armstrong, D., Stewart, R., & Hotopf, M. (2019). Common mental disorders within chronic inflammatory disorders: A primary care database prospective investigation. Annals of the Rheumatic Diseases, 78(5), 688–695. https://doi.org/10.1136/annrheumdis-2018-214676
Fair, D. C., Nocton, J. J., Panepinto, J. A., Yan, K., Zhang, J., Rodriguez, M., & Olson, J. (2022). Anxiety and depressive symptoms in juvenile idiopathic arthritis correlate with pain and stress using PROMIS measures. The Journal of Rheumatology, 49(1), 74–80. https://doi.org/10.3899/jrheum.210101
Yan, Y., Rychlik, K. L., Rosenman, M. B., & Miller, M. L. (2020). Use of PROMIS® to screen for depression in children with arthritis. Pediatric Rheumatology Online Journal, 18(1), 92. https://doi.org/10.1186/s12969-020-00482-1
Milatz, F., Albrecht, K., Minden, K., Marschall, U., Klotsche, J., & Callhoff, J. (2024). Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: An analysis of German nationwide health insurance data. Pediatric Rheumatology Online Journal, 22(1), 10. https://doi.org/10.1186/s12969-023-00948-y
Berthold, E., Dahlberg, A., Jöud, A., Tydén, H., Månsson, B., Kahn, F., & Kahn, R. (2022). The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis: Results from the south-Swedish juvenile idiopathic arthritis cohort. Pediatric Rheumatology Online Journal, 20(1), 114. https://doi.org/10.1186/s12969-022-00765-9
Milatz, F., Klotsche, J., Niewerth, M., Sengler, C., Windschall, D., Kallinich, T., Dressler, F., Trauzeddel, R., Holl, R. W., Foeldvari, I., Brück, N., Temming, S., Hospach, T., Warschburger, P., Berendes, R., Erbis, G., Kuemmerle-Deschner, J. B., Weller-Heinemann, F., Haas, J. P., Müller-Stierlin, A. S., Mutter, A., Meissner, T., Baumeister, H., & Minden, K. (2024). Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: Results of an outpatient screening. Arthritis Research & Therapy, 26(1), 82. https://doi.org/10.1186/s13075-024-03312-x
Li, L., Merchant, M., Gordon, S., Lang, B., Ramsey, S., Huber, A. M., Gillespie, J., Lovas, D., & Stringer, E. (2023). High rates of symptoms of major depressive disorder and panic disorder in a Canadian sample of adolescents with juvenile idiopathic arthritis. The Journal of Rheumatology, 50(6), 804–808. https://doi.org/10.3899/jrheum.220067
Roemer, J., Klein, A., & Horneff, G. (2023). Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis. Rheumatology International, 43(8), 1497–1505. https://doi.org/10.1007/s00296-023-05323-4
Bano, S., Bosan, K., Khurshid, S., Rasheed, U., Zeb, A., & Zammurrad, S. (2020). Prevalence of depression in patients with juvenile idiopathic arthritis presenting at a tertiary care hospital. Cureus, 12(1), e6807. https://doi.org/10.7759/cureus.6807
Duangmala, P., & Sontichai, W. (2025). Depression and anxiety in childhood-onset systemic lupus erythematosus: Prevalence, associated factors, and impact on quality of life and family. Pediatric Rheumatology Online Journal, 23(1), 15. https://doi.org/10.1186/s12969-025-01067-6
Donnelly, C., Cunningham, N., Jones, J. T., Ji, L., Brunner, H. I., & Kashikar-Zuck, S. (2018). Fatigue and depression predict reduced health-related quality of life in childhood-onset lupus. Lupus, 27(1), 124–133. https://doi.org/10.1177/0961203317716317
Datyner, E., Dingle, J., Newsome, V., Buckley, L. H., Belsky, N., Park, S., Mitchell, M., Fine, B., Patterson, B., Graham, T. B., & Davis, A. (2025). Increasing and maintaining rates of standardized depression screening in youth with childhood-onset systemic lupus erythematosus in a pediatric rheumatology clinic. Pediatric Rheumatology Online Journal, 23(1), 3. https://doi.org/10.1186/s12969-024-01038-3
Neufeld, K. M., Moaf, P., Quilter, M., Danguecan, A. N., Couture, J., Dominguez, D., Hendrikx, O., Ng, L., Schachter, R., Korczak, D. D., Levy, D. M., Hiraki, L., & Knight, A. M. (2024). Evaluation of depressive and anxiety symptoms in childhood-onset systemic lupus erythematosus: Frequency, course, and associated risk factors. Lupus, 33(8), 874–885. https://doi.org/10.1177/09612033241254170
Quilter, M., Hiraki, L., Knight, A. M., Couture, J., Levy, D., Silverman, E. D., Danguecan, A. N., Ng, L., Dominguez, D., Cost, K. T., Neufeld, K. M., Schachter, R., & Korczak, D. J. (2021). Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus. Lupus, 30(8), 1327–1337. https://doi.org/10.1177/09612033211018504
Rubinstein, T. B., Dionizovik-Dimanovski, M., Davis, A. M., Smith, C., Faust, L., Rutstein, B., Mitchell, M., Jones, J. T., Harris, J. G., Rodriguez, M., Tesher, M., Onel, K., Gabbay, V., Stein, R. E. K., von Scheven, E., Knight, A. M., & CARRA Mental Health Workgroup. (2023). Multicenter study of utility and acceptability of depression and anxiety screening in adolescents and young adults with childhood-onset systemic lupus. Arthritis Care & Research, 75(4), 724–733. https://doi.org/10.1002/acr.24825
Davis, A. M., Graham, T. B., Zhu, Y., & McPheeters, M. L. (2018). Depression and medication nonadherence in childhood-onset systemic lupus erythematosus. Lupus, 27(9), 1532–1541. https://doi.org/10.1177/0961203318779710
Roemer, J., Klein, A., & Horneff, G. (2023). Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis. Rheumatology International, 43(8), 1497–1505. https://doi.org/10.1007/s00296-023-05323-4
Çagliyan Türk, A., & Şahin, F. (2019). Prevalence of juvenile fibromyalgia syndrome among children and adolescents and its relationship with academic success, depression and quality of life, Çorum Province, Turkey. Archives of Rheumatology, 35(1), 68–77. https://doi.org/10.5606/ArchRheumatol.2020.7458
Arnold, L. M., Bateman, L., Palmer, R. H., & Lin, Y. (2015). Preliminary experience using milnacipran in patients with juvenile fibromyalgia: Lessons from a clinical trial program. Pediatric Rheumatology Online Journal, 13, 27. https://doi.org/10.1186/s12969-015-0025-9
Durmaz, Y., Alayli, G., Canbaz, S., Zahiroglu, Y., Bilgici, A., Ilhanli, I., & Kuru, O. (2013). Prevalence of juvenile fibromyalgia syndrome in an urban population of Turkish adolescents: Impact on depressive symptoms, quality of life and school performance. Chinese Medical Journal, 126(19), 3705–3711. https://doi.org/10.3760/cma.j.issn.0366-6999.20130185
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Julia Szklarska-Komenda, Maciej Komenda, Katarzyna Garncarz, Krzysztof Jamroch, Aleksandra Marek, Karolina Dziki, Wiktoria Dybizbańska, Zofia Nowakowska, Agnieszka Burzej, Mateusz Kacalak

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

